ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced regulatory approval from the Ministry of Health, Labor and Welfare (MHLW), in addition to reimbursement approval, for the Angio-Seal™ STS Plus Vascular Closure device. Angio-Seal STS Plus is designed to provide physicians with an improved method of sealing catheterization sites, allowing patients increased comfort and offering hospitals improved efficiencies. Approved for both percutaneous peripheral and cardiac interventional catheterization procedures, the device enables physicians to quickly seal femoral artery punctures made during those procedures.
